Numerate is a group of cutting-edge scientists and engineers trying to solve very difficult problems at the interface of data science, machine learning, cloud scale analytics and medicinal chemistry. We have developed a computational platform that can predict how a potential drug will behave in the lab and the body. We use this platform to process large spaces of chemistry while searching for therapies for some of the world’s most important diseases, such as, obesity, heart failure, Alzheimer’s, and Huntington’s disease. Our platform makes the drug development process cheaper, faster, and results in higher success rates than traditional approaches.
San Bruno, US
15 (est)

Key People at Numerate

Guido Lanza

Guido Lanza

Chief Executive Officer
John Griffin

John Griffin

Chief Scientific Officer
Brandon Allgood

Brandon Allgood

Chief Technology Officer

Numerate Locations

San Bruno, US

Numerate Metrics

Numerate Summary

Founding Date


Total Funding

$17.4 M

Latest funding size

$8.24 M

Time since last funding

over 2 years


Numerate Company Life